5 Abilify Diabetes Lawsuits Dismissed By New York Court For Forum Non Conveniens
NEW YORK — A New York state court justice on Oct. 23 dismissed five Abilify diabetes cases on the grounds of forum non conveniens provided defendants Bristol-Myers Squibb Co. (BMS) and...To view the full article, register now.
Already a subscriber? Click here to view full article